🔎 Trials Near Me

Akèy › Demans › Massachusetts

Etid klinik pou Demans nan Massachusetts

17 etid pou Demans ap chèche patisipan nan sit nan Massachusetts.

Vil nan Massachusetts

Tèks ofisyèl etid la (Anglè)

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

  • Local Institution - 0080, Watertown
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Sep 17, 2026 · NCT06976203

Dexmedetomidine Transdermal Systems (DMTS) Treatment for Agitation Associated With Dementia of the Alzheimer's Type

  • Vitalix, Worcester
Ap rekriteFaz 2
Tout laj · Tout sèks · Mizajou Sep 16, 2026 · NCT06052254

The BRAIN App (Phase 2 SBIR)

  • Hopeful Aging, Winchester
Ap rekrite
Laj 65 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT06298474

Making Connections Thru Music

  • Hopeful Aging, Winchester
  • The Hearthstone Institute, LLC, Winchester
Ap rekriteVolontè an sante akeyi
Laj 18 a 103 · Tout sèks · Mizajou Sep 15, 2026 · NCT06079216

Sleep and Circadian Rhythm Biomarkers of Postoperative Delirium

  • Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 70 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT06052397

Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

  • VA Boston Healthcare System, Boston
Ap rekriteFaz 4Volontè an sante akeyi
Laj 75 ak plis · Tout sèks · Mizajou Sep 1, 2026 · NCT04262206

A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

  • Massachusetts General Hospital (MGH), Charlestown
Ap rekriteFaz 1
Laj 50 a 85 · Tout sèks · Mizajou Aug 24, 2026 · NCT06297590

A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

  • Boston Center for Memory, Newton
Ap rekriteFaz 3
Laj 60 a 85 · Tout sèks · Mizajou Aug 20, 2026 · NCT06976216

Home-Based Brain Stimulation for Motoric Cognitive Risk Syndrome

  • Hebrew Rehabilitation Center, Roslindale
Ap rekrite
Laj 65 a 90 · Tout sèks · Mizajou Jul 16, 2026 · NCT06821568

A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

  • Boston Center for Memory, Newton
  • MedVadis Research Corporation, Waltham
Ap rekriteFaz 3
Laj 55 ak plis · Tout sèks · Mizajou Jul 7, 2026 · NCT07602582

A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  • ActivMed Practices and Research, Methuen
Ap rekriteFaz 2
Laj 50 a 85 · Tout sèks · Mizajou Jun 26, 2026 · NCT07094516

Trial-Ready Cohort-Down Syndrome (TRC-DS)

  • Massachusetts General Hospital, Co-Enrolling through ABC-DS Only, Boston
Ap rekriteEtid obsèvasyon
Laj 25 a 55 · Tout sèks · Mizajou May 18, 2026 · NCT04165109

Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease

  • Center for Alzheimer Research and Treatment, Brigham and Women's Hospital, Boston
Ap rekriteFaz 2
Laj 60 a 85 · Tout sèks · Mizajou Feb 12, 2026 · NCT06489548

Non-invasive Brain Stimulation for Cognitive and Motor Dysfunction in Dementia

  • Hinda and Arthur Marcus Institute for Aging Research, Boston
Ap rekrite
Laj 55 ak plis · Tout sèks · Mizajou Jan 12, 2026 · NCT05661084

Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer's Disease and Other Dementias 2.0

  • Hebrew SeniorLife, Boston
Ap rekrite
Laj 60 a 106 · Tout sèks · Mizajou Jan 6, 2026 · NCT05950607

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

  • McLean Hospital, Belmont
Ap rekriteEtid obsèvasyon
Laj 18 a 89 · Tout sèks · Mizajou Nov 6, 2025 · NCT05245903

Assess Fibrin in Brains With AD/ADRD

  • Massachusetts General Hospital, Boston
Ap rekriteFaz 1/2Volontè an sante akeyi
Laj 55 a 90 · Tout sèks · Mizajou Oct 30, 2025 · NCT05336695

Sous ClinicalTrials.gov, done yo ranmase Oct 3, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.